Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-02-22 @ 5:22 PM
Study NCT ID:
NCT02672358
Status:
WITHDRAWN
Last Update Posted:
2018-08-10
First Post:
2016-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-09-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12-07
Completion Date Type:
ESTIMATED
First Submit Date:
2016-02-01
First Submit QC Date:
None
Study First Post Date:
2016-02-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-08
Last Update Post Date:
2018-08-10
Last Update Post Date Type:
ACTUAL